The National Health Research Institute (NHRI) and the National Defense Medical Center yesterday announced a prototype COVID-19 rapid diagnostic kit that can provide results in about 15 minutes.
The NHRI and the center’s Institute of Preventive Medicine used SARS-CoV antibodies produced during the SARS outbreak in 2003 and picked out one that can identify SARS-CoV-2, which causes COVID-19, to develop the rapid test kit.
After spending a month developing the test kit, the institutes yesterday in Taipei presented the prototype to pharmaceutical companies in the hope of achieving technology transfers and starting mass production.
Photo: Liu Hsin-de, Taipei Times
The test works by placing a specimen taken from the mouth or nose onto a test strip, which siphons the specimen toward the antibodies on the strip, NHRI National Institute of Infectious Disease and Vaccinology Director Liao Ching-len (廖經綸) said.
As researchers have identified the coronavirus’ spike protein, if the specimen contains SARS-CoV-2, the spike protein would be caught by the antibody and two lines would appear on the test strip, indicating a positive result, he said.
The results are shown in a similar fashion to a pregnancy test — one line means negative and two lines means positive — Liao said.
The prototype has been proven to avoid cross-reaction with other viruses, including human coronaviruses OC43, 229E and NL63; adenoviruses; respiratory syncytial virus; type A influenza viruses H1N1, H5N1 and H7N9; and enterovirus 71, he said.
The prototype is not meant to replace the real-time reverse transcription polymerase chain reaction test, which is currently being used for diagnosis, he said, adding that they hope the rapid test will be used as a complementary measure to allow hospitals to screen patients rapidly and sort them, Liao said.
They also hope experienced pharmaceutical companies can join them in refining the prototype, and manufacture and release the final product for front line disease prevention, he added.
NHRI President Liang Kung-yee (梁賡義) said that the Food and Drug Administration has also launched a scheme, which grants permission for clinical trials and mass production at the same time, to shorten the duration required for a product to hit the market.
If the procedures go smoothly, the test kit could be out in three months, Liang said.
Other countries have also expressed an interest in technology transfers, but the NHRI wants to give priority to Taiwanese companies, he added.
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
BEIJING’S ‘PAWN’: ‘We, as Chinese, should never forget our roots, history, culture,’ Want Want Holdings general manager Tsai Wang-ting said at a summit in China The Mainland Affairs Council (MAC) yesterday condemned Want Want China Times Media Group (旺旺中時媒體集團) for making comments at the Cross-Strait Chinese Culture Summit that it said have damaged Taiwan’s sovereignty, adding that it would investigate if the group had colluded with China in the matter and contravened cross-strait regulations. The council issued a statement after Want Want Holdings (旺旺集團有限公司) general manager Tsai Wang-ting (蔡旺庭), the third son of the group’s founder, Tsai Eng-meng (蔡衍明), said at the summit last week that the group originated in “Chinese Taiwan,” and has developed and prospered in “the motherland.” “We, as Chinese, should never
RSS